ProCE Banner Events

Share

Practical Guidance for the Multidisciplinary Team on Therapeutics Targeting Protein Degradation Pathways in NHL

Register now for this interactive workshop series to learn more about the rationale for targeting protein degradation pathways in non-Hodgkin lymphoma (NHL), and the emerging role of cereblon E3 ligase modulators (CELMoDs) in the personalized care of patients with NHL. After the meeting, download the associated slideset for use in your clinic.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Physicians ABIM MOC: maximum of 1.00 Medical Knowledge MOC point

Who Should Attend

This activity has been designed to meet the educational needs of oncologists, nurse practitioners, physician associates, oncology nurses, pharmacists, and other healthcare professionals involved in the management of NHL. 

Time and location

Wednesday, December 04, 2024

8:00 AM - 9:00 AM Pacific Time (PT)

Virtual

CCO Simulcast | Host Group ID
Post Falls, Idaho

Faculty
Julio C Chavez, MD, MS

Associate Member
ICE-T Clinical Research Medical Director Hematologic Malignancies
H. Lee Moffitt Cancer Center and Research Institute
Associate Professor
University of South Florida
Tampa, Florida

Agenda

  • Welcome and Introduction

  • Rationale for Targeting the Ubiquitin-Proteasome System in NonHodgkin Lymphoma (NHL)

  • Overcoming the Limitations of Currently Available NHL Therapies With Protein Degraders

  • Case Scenarios of Where Cereblon E3 Ligase Modulators (CELMoDs) May Fit Within Future NHL Treatment Paradigms

  • Review of Ongoing Clinical Trials of CELMoDs in NHL and Eligibility Criteria

  • Question and Answer Session

Location

Venue Name

CCO Simulcast | Host Group ID

Address

CCO Simulcast | Host Group ID
Post Falls, Idaho

CME/CE Info

Goal Statement
The goal of this program is to improve learners’ understanding of the latest data on investigational protein degradation pathway inhibitors for the treatment of NHL in preparation for clinical use of these agents. 

Target Audience
This activity has been designed to meet the educational needs of oncologists, nurse practitioners, physician associates, oncology nurses, pharmacists, and other healthcare professionals involved in the management of NHL.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Describe the unique mechanism of action of CELMoDs in NHL, including anti-malignant effects as well as modulation of non-malignant components of the tumor microenvironment
  • Evaluate the efficacy data as well as safety and tolerability profiles of investigational agents that target protein degradation pathways in NHL treatment, specifically considering the potential clinical application of CELMoDs
  • Identify eligible patients with NHL who are candidates for enrollment on ongoing clinical trials evaluating novel protein degraders

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour, including 1.0 hour of pharmacotherapy credit.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-24-266-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification 

A blue and black sign with white textDescription automatically generated

Successful completion of this CME activity, which included participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Bristol Myers Squibb.

Contact Information

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.